Richardson F C, Tennant B C, Meyer D J, Richardson K A, Mann P C, McGinty G R, Wolf J L, Zack P M, Bendele R A
NeXstar Pharmaceuticals, Inc., Boulder, Colorado 80301, USA.
Toxicol Pathol. 1999 Nov-Dec;27(6):607-17. doi: 10.1177/019262339902700601.
The toxicities of 2'-fluorouridine (2'-FU) and 2'-fluorocytidine-HCl (2'-FC) were separately evaluated in 2 species, male Fischer 344 (F334) rats and woodchucks. Particular attention was focused on the ability of these nucleosides to induce toxicities similar to those induced by the antiviral drug fialuridine (FIAU). 2'-FU or 2'-FC was administered to F344 male rats by intravenous injection at doses of 5, 50, and 500 mg/kg/day for 90 consecutive days and to male and female woodchucks at doses of 0.75 and 7.5 mg/kg/day for 90 consecutive days. Clinical chemistry, hematology, and urinalysis (woodchuck only) profiles were assessed during and at the termination of the study. At necropsy, organs were weighed and tissues collected for routine histologic analysis. Cytochrome c oxidase activity, citrate synthase activity, and mitochondrial DNA content were measured, and micronucleus formation in the bone marrow (rats only) was evaluated. No adverse clinical effects were observed in either species. Rats treated with high doses of either 2'-FU or 2'-FC had body weights that were 90% of those of controls. 2'-FU and 2'-FC both induced a moderate decrease in the median lymphocyte count, and 2'-FC and 2'-FU induced a mild increase in mean corpuscular hemoglobin and mean corpuscular volume. Both compounds caused slight to moderate, reversible, histologic changes in the spleen and thymus. In the woodchuck, 2'-FC caused a slight increase in mean absolute lymphocytes, and 2'-FC and 2'-FU slightly increased hepatic periportal vacuolation and/or mononuclear cell infiltration. In summary, neither compound showed evidence of the toxicity induced by fialuridine in either species. Although compound effects were observed, none of these effects were considered to be adverse, and the no-observed adverse effect level was determined to be 500 mg/kg/day for both compounds in the male F344 rat and 7.5 mg/kg/day in the woodchuck.
分别在两种动物,即雄性Fischer 344(F334)大鼠和土拨鼠中评估了2'-氟尿苷(2'-FU)和盐酸2'-氟胞苷(2'-FC)的毒性。特别关注这些核苷诱导与抗病毒药物非阿尿苷(FIAU)相似毒性的能力。将2'-FU或2'-FC通过静脉注射给予F344雄性大鼠,剂量分别为5、50和500mg/kg/天,连续90天;给予雄性和雌性土拨鼠的剂量分别为0.75和7.5mg/kg/天,连续90天。在研究期间和结束时评估临床化学、血液学和尿液分析(仅针对土拨鼠)指标。尸检时,对器官进行称重,并收集组织进行常规组织学分析。测量细胞色素c氧化酶活性、柠檬酸合酶活性和线粒体DNA含量,并评估骨髓中的微核形成(仅针对大鼠)。在这两种动物中均未观察到不良临床影响。用高剂量2'-FU或2'-FC处理的大鼠体重为对照组的90%。2'-FU和2'-FC均导致淋巴细胞中位数计数适度下降,2'-FC和2'-FU导致平均红细胞血红蛋白和平均红细胞体积轻度增加。两种化合物均引起脾脏和胸腺轻微至中度、可逆的组织学变化。在土拨鼠中,2'-FC导致平均绝对淋巴细胞数略有增加,2'-FC和2'-FU使肝门周空泡化和/或单核细胞浸润略有增加。总之,在这两种动物中,两种化合物均未表现出非阿尿苷诱导的毒性迹象。尽管观察到了化合物的作用,但这些作用均不被认为是有害的,并且确定雄性F344大鼠中两种化合物的未观察到有害作用水平均为500mg/kg/天,土拨鼠中为7.5mg/kg/天。